Glenmark gets FDA fungal cream nod; ACEA gets funds from Qiming, Lilly;

> India's Glenmark Pharma has received final approval from the U.S. FDA for a cream used to treat fungal skin infections. Report

> Qiming Venture Partners and Lilly Asia Ventures provided $30 million in a new round of venture funding for ACEA Biosciences which has several clinical trials underway in China. Release

> The Tsinghua University Center for Statistical Science has created a "big data" center to focus on medical data and methodology development and applications, according to a report by China Daily. Report

> Singapore state investor GIC is investing $85 million in Bloomage BioTechnology, an aesthetic drug maker, which Bloomage said will help it grow organically and via acquisitions. Report